Showing 20 of 104 recruiting trials for “sickle-cell-beta-thalassemia-disease”
Clinical Study of BRL-101 in Severe SCD
👨⚕️ Yongrong Lai, phD, First Affiliated Hospital of Guangxi Medical University📍 1 site📅 Started Jul 2024View details ↗
Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
Predictors of Pain in Sickle Cell Disease
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
RecruitingNCT06497153 ↗
Lung Ultrasound in Pediatric Acute Chest Syndrome
👨⚕️ Aurélie HAYOTTE, MD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Jun 2024View details ↗
RecruitingNCT07000747 ↗
Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients
A Long-term Follow-up Study in Participants Who Received CS-101
👨⚕️ Xiaowen Zhai, M.D., Children's Hospital of Fudan University📍 1 site📅 Started Jun 2024View details ↗
Enrolling by InvitationNCT06363760 ↗
A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
Inspiratory Muscle Training in Children With Beta Thalasemia
👨⚕️ hagar el-hadidy, lecturer, Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt📍 1 site📅 Started Jun 2024View details ↗
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
👨⚕️ John F Tisdale, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started May 2024View details ↗
An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia
Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia
🏥 National Institute of Blood and Marrow Transplant (NIBMT), Pakistan📍 1 site📅 Started Apr 2024View details ↗
Β-Thalassemia Treatment with KL003 Cell Injection
SMYLS Multi-site Trial
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
👨⚕️ Robert Nickel, MD, Children's National Research Institute📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06073860 ↗
A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
CS-101 in Patients With β-thalassemia
👨⚕️ Yongrong Lai, M.D., First Affiliated Hospital of Guangxi Medical University📍 1 site📅 Started Mar 2024View details ↗
Acupressure in Patients With Sickle Cell Disease
RecruitingNCT06271512 ↗
A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major
👨⚕️ Sujiang Zhang, M.D., Shanghai Ruijin Hospital, Shanghai Jiaotong University📍 3 sites📅 Started Jan 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →